Candriam SCA’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Hold |
0
| – | -$2.32M | – | 848 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 475 |
|
|
2018
Q2 | – | Sell |
-70,631
| Closed | -$1.21M | – | 824 |
|
|
2018
Q1 | $1.21M | Sell |
70,631
-1,277
| -2% | -$21.8K | 0.02% | 557 |
|
|
2017
Q4 | $1.36M | Buy |
71,908
+20,000
| +39% | +$379K | 0.02% | 526 |
|
|
2017
Q3 | $914K | Buy |
51,908
+40,033
| +337% | +$705K | 0.02% | 583 |
|
|
2017
Q2 | $395K | Sell |
11,875
-1,201
| -9% | -$39.9K | 0.01% | 668 |
|
|
2017
Q1 | $420K | Sell |
13,076
-42,064
| -76% | -$1.35M | 0.01% | 656 |
|
|
2016
Q4 | $2M | Buy |
55,140
+4,007
| +8% | +$145K | 0.05% | 372 |
|
|
2016
Q3 | $2.35M | Sell |
51,133
-8,066
| -14% | -$371K | 0.06% | 328 |
|
|
2016
Q2 | $2.97M | Sell |
59,199
-1,354
| -2% | -$68K | 0.08% | 251 |
|
|
2016
Q1 | $3.22M | Buy |
60,553
+7,560
| +14% | +$402K | 0.08% | 256 |
|
|
2015
Q4 | $3.48M | Sell |
52,993
-6,000
| -10% | -$394K | 0.09% | 232 |
|
|
2015
Q3 | $3.33M | Sell |
58,993
-43,730
| -43% | -$2.47M | 0.08% | 258 |
|
|
2015
Q2 | $6.07M | Sell |
102,723
-1,318
| -1% | -$77.9K | 0.13% | 206 |
|
|
2015
Q1 | $6.48M | Buy |
104,041
+28,340
| +37% | +$1.77M | 0.13% | 205 |
|
|
2014
Q4 | $4.35M | Buy |
+75,701
| New | +$4.35M | 0.09% | 258 |
|